Aardvark Therapeutics, Inc.
AARD
$4.10
-$0.44-9.69%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 91.20M | 110.03M | 126.35M | 141.82M | 151.26M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.38M | 1.86M | 2.86M | 2.95M | 3.29M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 93.58M | 111.89M | 129.21M | 144.77M | 154.55M |
|
|
|||||
| Total Current Assets | 93.58M | 111.89M | 129.21M | 144.77M | 154.55M |
| Net Property, Plant & Equipment | 269.00K | 355.00K | 439.00K | 522.00K | 628.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.74M | 4.94M | 3.58M | 2.19M | 1.84M |
| Total Assets | 98.59M | 117.18M | 133.23M | 147.48M | 157.03M |
|
|
|||||
| Total Accounts Payable | 4.49M | 2.07M | 4.44M | 5.06M | 2.56M |
| Total Accrued Expenses | 6.78M | 8.04M | 5.86M | 4.84M | 3.03M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 336.00K | 441.00K | 429.00K | 417.00K | 390.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 11.60M | 10.55M | 10.74M | 10.31M | 5.98M |
|
|
|||||
| Total Current Liabilities | 11.60M | 10.55M | 10.74M | 10.31M | 5.98M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 116.00K | 228.00K | 336.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 12.00K | 24.00K |
| Total Liabilities | 11.60M | 10.55M | 10.85M | 10.55M | 6.34M |
|
|
|||||
| Common Stock & APIC | 224.48M | 222.47M | 220.62M | 218.93M | 218.28M |
| Retained Earnings | -137.51M | -115.92M | -98.32M | -82.00M | -67.64M |
| Treasury Stock & Other | 14.00K | 81.00K | 82.00K | -3.00K | 44.00K |
| Total Common Equity | 86.99M | 106.63M | 122.38M | 136.93M | 150.69M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 86.99M | 106.63M | 122.38M | 136.93M | 150.69M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 86.99M | 106.63M | 122.38M | 136.93M | 150.69M |
|
|
|||||